Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis

Journal of Periodontology

Volumn 81, Issue 2, 2010, Pages 251-259

  Reinhardt, Richard A ^a   Stoner, Julie A ^b   Golub, Lorne M ^c   Lee, Hsi Ming ^c   Nummikoski, Pirkka V ^d   Sorsa, Timo ^e   Payne, Jeffrey B ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Doxycycline; Gingival crevicular fluid; Interleukin 1; Matrix metalloproteinase 8; Periodontitis; Type I collagen

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; DOXYCYCLINE; INTERLEUKIN 1BETA; NEUTROPHIL COLLAGENASE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; GINGIVITIS; HOSPITALIZATION; HUMAN; IMMUNOLOGY; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTAL POCKET; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK; RISK ASSESSMENT;

AGED; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; BONE RESORPTION; DISEASE PROGRESSION; DOXYCYCLINE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; ODDS RATIO; PERIODONTAL ATROPHY; PERIODONTAL POCKET; POSTMENOPAUSE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 77649228649     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090374     Document Type: Article

References (32)

1. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol 1997;2:123-137.
2. Sorsa T, Tjäderhane L, Konttinen YT, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321.
3. Golub LM, Lee HM, Stoner JA, et al. Subantimicrobialdose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women. J Periodontol 2008;79:1409-1418.
4. Payne JB, Stoner JA, Nummikoski PV, et al. Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women. J Clin Periodontol 2007;34:776-787.
5. Kirkwood KL, Golub LM, Bradford PG. Non-antimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts. Ann N Y Acad Sci 1999; 878:667-670.
6. Golub LM, Ramamurthy NS, Llavaneras A, et al. A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann N Y Acad Sci 1999;878:290-310.
7. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319.
8. Reinhardt RA, Stoner JA, Golub LM, et al. Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: Clinical outcomes. J Clin Periodontol 2007; 34:768-775 (erratum 2007;34:1097)
9. Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: Effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001;28:146-156.
10. Reinhardt RA, Payne JB, Maze CA, Patil KD, Gallagher SJ, Mattson JS. Influence of estrogen and osteopenia/ osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol 1999;70:823-828.
11. Caton JG, Ciancio SG, Blieden TM, et al. Treatment of subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000;71:521-532.
12. Preshaw PM, Hefti AF, Novak MJ, et al. Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: A multicenter trial. J Periodontol 2004;75:1068-1076.
13. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin 1b in tissue from sites of active periodontal disease. J Clin Periodontol 1991;18:548-554.
14. Suwatanapongched P, Laohapand P, Surarit R, Ohmoto Y, Ruxrungtham K. Interleukin-1 beta level in gingival crevicular fluid of patients with active periodontitis. Asian Pac J Allergy Immunol 2000;18:201-207.
15. Silva N, Dutzan N, Hernandez M, et al. Characterization of progressive periodontal lesions in chronic periodontitis patients: Levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. J Clin Periodontol 2008;35: 206-214.
16. Lee HJ, Kang IK, Chung CP, Choi SM. The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. J Clin Periodontol 1995;22: 885-890.
17. Fine DH, Markowitz K, Furgang D, et al. Macrophage inflammatory protein-1a: A salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease? J Periodontol 2009;80:106-113.
18. Herr AE, Hatch AV, Giannobile WV, et al. Integrated microfluidic platform for oral diagnostics. Ann N Y Acad Sci 2007;1098:362-374.
19. Giannobile WV, Lynch SE, Denmark RG, Paquette DW, Fiorellini JP, Williams RC. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type 1 collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J Clin Periodontol 1995;22:903-910.
20. Oringer RJ, Al-Shammari KF, Aldredge WA, et al. Effect of locally delivered minocycline microspheres on markers of bone resorption. J Periodontol 2002; 73:835-842.
21. Lee W, Aitken S, Kulkarni G, et al. Collagenase activity in recurrent periodontitis: Relationship to disease progression and doxycycline therapy. J Periodontal Res 1991;26:479-485.
22. Bader HI, Boyd RL. Long-term monitoring of adult periodontitis patients in supportive periodontal therapy: Correlation of gingival crevicular fluid proteases with probing attachment loss. J Clin Periodontol 1999; 26:99-105.
23. Mäntylä P, Stenman M, Kinane D, et al. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res 2006;41:503-512.
24. Kinane DF, Darby IB, Said S, et al. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res 2003;38:400-404.
25. Buduneli N, Vardar S, Atilla G, Sorsa T, Luoto H, Baylas H. Gingival crevicular fluid matrix metalloproteinase- 8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. J Periodontol 2002;73:103-109.
26. Okuda K, Miyazaki A, Momose M, et al. Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN). J Periodontal Res 2001;36:309-316.
27. Albandar JM. Epidemiology and risk factors of periodontal diseases. Dent Clin North Am 2005;49:517-532.
28. Lagervall M, Jansson L. Relationship between tooth loss/probing depth and systemic disorders in periodontal patients. Swed Dent J 2007;31:1-9.
29. Nomura T, Ishii A, Oishi Y, Kohma H, Hara K. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: The relevance to periodontal diseases. Oral Dis 1998;4:231-240.
30. Miller CS, King CP Jr., Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: A cross-sectional study. J Am Dent Assoc 2006;137:322-329.
31. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997;272:31504-31509.
32. Sorsa T, Hernández M, Leppilahti J, Munjal S, Netuschil L, Mäntylä P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chairside methods. Oral Dis 2009 July 15. [Epub ahead of print].